These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25112861)

  • 1. Prostate cancer: USPSTF screening recommendation could lead to greater numbers of avoidable deaths.
    Fenner A
    Nat Rev Urol; 2014 Sep; 11(9):481. PubMed ID: 25112861
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.
    Joshi SS; Filson CP
    Cancer; 2020 Feb; 126(4):694-696. PubMed ID: 31794066
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.
    Eapen RS; Herlemann A; Washington SL; Cooperberg MR
    Curr Opin Urol; 2017 May; 27(3):205-209. PubMed ID: 28221220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. US expert panel recommends against prostate cancer screening.
    Lenzer J; Brownlee S
    BMJ; 2011 Oct; 343():d6479. PubMed ID: 21987717
    [No Abstract]   [Full Text] [Related]  

  • 5. The current state of prostate-specific antigen testing.
    Lewis R; Hornberger B
    JAAPA; 2016 Sep; 29(9):51-3. PubMed ID: 27575906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.
    Fleshner K; Carlsson SV; Roobol MJ
    Nat Rev Urol; 2017 Jan; 14(1):26-37. PubMed ID: 27995937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer: PSA update--no change yet.
    Phillips R
    Nat Rev Urol; 2014 Sep; 11(9):483. PubMed ID: 25134834
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer: Draft USPSTF 2017 recommendation on PSA testing - a sea-change?
    Van der Kwast TH; Roobol MJ
    Nat Rev Urol; 2017 Aug; 14(8):457-458. PubMed ID: 28607501
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.
    Carlsson S; Vickers AJ; Roobol M; Eastham J; Scardino P; Lilja H; Hugosson J
    J Clin Oncol; 2012 Jul; 30(21):2581-4. PubMed ID: 22711853
    [No Abstract]   [Full Text] [Related]  

  • 10. The pendulum swings back: Screening for prostate cancer in 2018.
    Thompson IM
    Cancer; 2018 Jul; 124(13):2690-2692. PubMed ID: 29786846
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grading the new US Preventive Services Task Force prostate cancer screening recommendation.
    Volk RJ; Wolf AM
    JAMA; 2011 Dec; 306(24):2715-6. PubMed ID: 22203540
    [No Abstract]   [Full Text] [Related]  

  • 13. Reevaluating PSA Testing Rates in the PLCO Trial.
    Shoag JE; Mittal S; Hu JC
    N Engl J Med; 2016 May; 374(18):1795-6. PubMed ID: 27144870
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate Cancer Screening - A Perspective on the Current State of the Evidence.
    Pinsky PF; Prorok PC; Kramer BS
    N Engl J Med; 2017 Mar; 376(13):1285-1289. PubMed ID: 28355509
    [No Abstract]   [Full Text] [Related]  

  • 15. USPSTF finds little evidence to support advising PSA screening in any man.
    Slomski A
    JAMA; 2011 Dec; 306(23):2549-51. PubMed ID: 22187266
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate cancer: what is the right message?
    Glina S; Pasternak J
    Einstein (Sao Paulo); 2015; 13(4):7-8. PubMed ID: 26761546
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of recommendations against prostate cancer screening with prostate specific antigen].
    Abascal Junquera JM; Fumadó Ciutat L; Francés Comalat A; Cecchini Rosell L
    Med Clin (Barc); 2016 Oct; 147(8):361-365. PubMed ID: 27085747
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate-specific antigen (PSA) testing on PSA testing in Australia.
    Zargar H; van den Bergh R; Moon D; Lawrentschuk N; Costello A; Murphy D
    BJU Int; 2017 Jan; 119(1):110-115. PubMed ID: 27454454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New US Preventive Service Task Force recommendations for prostate cancer screening: a needed update, but not enough.
    Wroclawski ML
    Einstein (Sao Paulo); 2017; 15(3):7-10. PubMed ID: 29091165
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate cancer: Prudent practice optimizes screening outcomes.
    Auvinen A
    Nat Rev Urol; 2016 Jul; 13(7):376-7. PubMed ID: 27215425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.